Skip to main content

Gut-Brain Connect: How metaMe’s Digital Therapeutic Hopes To Rewire IBS Treatment 

metaMe Health CEO and ex-Takeda executive Tim Rudolphi and partner firm Indegene’s senior vice president Marut Setia discuss with Scrip plans for the FDA-authorized, gut-directed hypnotherapy Regulora®, including an openness to outcomes-based pricing and the wider go-to-market strategy.

Links to a third-party site and requires registration for access to the full article.